
Are cell therapies the answer to age-related eye diseases?
In March 2026, Lineage Cell Therapeutics launched a new cell therapy programme for the treatment of corneal endothelial disease. Diana Turner caught up with Brian Culley, CEO of Lineage Cell Therapeutics, to find out more. DT: How do you hope your in-house AlloSCOPE platform can overcome the problems and practical hurdles associated with other cell… Read More

